FDA Approves Ryoncil Cell Therapy for Graft-versus-Host Disease (GVHD)F
Continue reading...
FDA Approves Ryoncil Cell Therapy for Graft-versus-Host Disease (GVHD)
FDA Approves Ryoncil Cell Therapy for Graft-versus-Host Disease (GVHD)
The U.S. Food and Drug Administration (FDA) has approved Mesoblast's cell therapy, Ryoncil, for the treatment...
